Market News (Page 57) - TendieTensor

Market News Page 57 of 293 • 7,310 articles

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

GlobeNewswire Inc. • Na

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

12/29/2025 09:00 AM • Nutriband Inc. announced the sale of a 90% stake in its subsidiary Pocono Pharmaceutical to EarthVision Bio for $5 million USD, with Nutriband shareholders retaining 10% ownership. The company plans to use proceeds to develop AVERSA Fentanyl, an abuse-deterrent opioid patch with potential annual US sales of $80-200 million. EarthVision Bio is developing sustainable product alternatives founded by Intel co-founder Dr. Gordon Moore and ex-Chevron Europe chairman Dr. Hans Franke.

NTRB - Company is raising capital ($5M) to fund development of its lead product AVERSA Fentanyl with significant market potential ($80-200M annual sales). The divestment of non-core subsidiary allows focus on higher-value pharmaceutical development. Retention of 10% stake in EarthVision Bio provides upside participation.

#asset sale #subsidiary divestment #abuse-deterrent fentanyl #transdermal pharmaceutical #sustainable products #opioid innovation

NDBT Elects Casey Plummer to Board of Directors

GlobeNewswire Inc. • Na

NDBT Elects Casey Plummer to Board of Directors

12/29/2025 09:00 AM • North Dallas Bank and Trust Co. (NDBT) announced the election of Casey Plummer to its Board of Directors, effective January 1, 2026. Plummer is the founder and principal of Plummer Development Company and serves as Treasurer for The Human Impact, a nonprofit serving the homeless population in Dallas. NDBT leadership praised Plummer's commitment to community service and business excellence.

NODB - The appointment of an accomplished business leader and community servant to the board demonstrates strong corporate governance and commitment to community engagement. The endorsement from CEO Larry Miller highlights leadership quality and the bank's values-driven culture.

#board appointment #community banking #real estate development #nonprofit partnership #Dallas #corporate governance

The AI Data Center Boom Goes Public: From “Neoclouds” to Power, Cooling, and the Grid

GlobeNewswire Inc. • Microcaps.Com

The AI Data Center Boom Goes Public: From “Neoclouds” to Power, Cooling, and the Grid

12/29/2025 09:00 AM • As AI infrastructure spending accelerates, public markets are increasingly valuing companies across the data center ecosystem—from GPU suppliers to cooling systems and asset-light platforms. Companies exposed to AI infrastructure trade at 20-30x revenue multiples, significantly higher than S&P 500 averages, reflecting investor confidence in long-term growth despite capital intensity and execution risks. The sector is evolving beyond the GPU race toward infrastructure readiness, with power, cooling, and interconnection becoming as critical as chips themselves.

NVDA - Positioned as a central player in AI infrastructure with prominent role in powering large-scale AI compute clusters; benefits from accelerating demand for GPUs as foundational to AI data center buildout.

#AI data centers #GPU infrastructure #valuation multiples #capital intensity #neoclouds #liquid cooling #power delivery #asset-light models #infrastructure investment

Verizon to report earnings January 30, 2026

GlobeNewswire Inc. • Na

Verizon to report earnings January 30, 2026

12/29/2025 09:00 AM • Verizon Communications Inc. announced it will report fourth-quarter 2025 earnings on January 30, 2026, with a webcast presentation at 8:00 a.m. ET. Materials will be available on the company's Investor Relations website starting at 6:30 a.m. ET.

VZ - The article is a factual announcement of an upcoming earnings report date and webcast. It contains no forward-looking statements, performance metrics, or information that would indicate positive or negative business developments. It is purely procedural in nature.

#earnings report #fourth-quarter 2025 #investor relations #webcast #financial results

Spain's Economic Resilience: Strong Growth, Low Inflation, And Structural Reforms Post-Pandemic

Benzinga • Mighty Wisdom

Spain's Economic Resilience: Strong Growth, Low Inflation, And Structural Reforms Post-Pandemic

12/29/2025 08:38 AM • Spain's economy has emerged as one of Europe's strongest performers with projected 2025 GDP growth of 2.5%, significantly above eurozone average. Key drivers include controlled inflation near 2.3%, employment reaching historical highs with unemployment at ~10%, strong tourism sector contributing €249 billion to GDP, and rapid renewable energy expansion now accounting for over 50% of electricity generation. High-value sectors including technology, professional services, and green infrastructure are fueling diversified growth.

WDGF - Article notes defense firms are experiencing increased demand linked to higher European defense spending, supporting growth prospects.

#Spain economy #GDP growth #inflation control #labor market reform #tourism #renewable energy #technology sector #eurozone #employment

REE Automotive Ties Up With BorgWarner Unit To Power Next-Gen EV Drive Systems

Benzinga • Lekha Gupta

REE Automotive Ties Up With BorgWarner Unit To Power Next-Gen EV Drive Systems

12/29/2025 08:32 AM • REE Automotive signed a strategic memorandum of understanding with Cascadia Motion (BorgWarner subsidiary) to co-develop next-generation electric drive units combining Cascadia Motion's iM-125 motor-inverter with REEcorner technology. The collaboration includes a royalty-based arrangement and targets OEM electrification initiatives. REE shares rose 4.64% in premarket trading.

CSCO - Jumped 4.5% after beating analyst expectations and providing positive guidance
REE - Strategic partnership with major automotive supplier BorgWarner expands REE's addressable market and validates its REEcorner technology. The deal includes royalty-based revenue potential and access to OEM customers. Stock price increased 4.64% in premarket trading, reflecting positive market reception.

#electric drive unit #REEcorner technology #software-defined vehicle #OEM electrification #strategic partnership #EV technology

Why One Investor Sold $6 Million of the MSCI China ETF Amid a Nearly 30% Run

The Motley Fool • Jonathan Ponciano

Why One Investor Sold $6 Million of the MSCI China ETF Amid a Nearly 30% Run

12/29/2025 08:30 AM • Hong Kong-based Fosun International completely exited its $5.84 million position in the iShares MSCI China ETF (MCHI) during Q3, selling 106,000 shares. The exit comes after the ETF surged nearly 30% year-to-date, reflecting a broad recovery in Chinese equities. The move reflects risk management and portfolio rebalancing rather than bearish sentiment on China, as investors trim exposure after strong gains to reallocate capital to better risk-reward opportunities.

MSTR - Shares declined for fourth straight session to lowest level in over a year
MCHI - The ETF experienced strong performance (30% YTD gain), but the investor's exit reflects tactical rebalancing and risk management rather than negative outlook. The article frames this as disciplined portfolio architecture following a sharp rebound, not a bearish signal on the fund itself.

#China ETF #portfolio exit #risk management #Chinese equities #institutional investor #profit-taking #rebalancing

Kratos Receives Approximately $30 Million in Air Defense and C5ISR System National-Security-Related Hardware Production Contracts

GlobeNewswire Inc. • Na

Kratos Receives Approximately $30 Million in Air Defense and C5ISR System National-Security-Related Hardware Production Contracts

12/29/2025 08:00 AM • Kratos Defense & Security Solutions announced it has received approximately $30 million in contracts for air defense and C5ISR system military-grade custom hardware production. The company will perform work in secure manufacturing facilities, leveraging its expertise in missile, radar, counter-UAS, and other complex defense systems.

AAPL - Part of tech sector experiencing investment shifts, but no specific negative indicators mentioned
KTOS - The company secured $30 million in new defense contracts, demonstrating strong customer confidence and continued demand for its military-grade hardware production capabilities. Leadership statements emphasize the company's competitive advantages in delivering mission-critical systems on time and at scale, indicating healthy business momentum and market position.

#defense contracts #military hardware #air defense systems #C5ISR #national security #manufacturing #hypersonic systems #counter-UAS

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

GlobeNewswire Inc. • Na

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

12/29/2025 08:00 AM • Praxis Precision Medicines received FDA Breakthrough Therapy Designation for ulixacaltamide, a T-type calcium channel inhibitor for essential tremor treatment, based on positive Phase 3 Essential3 program results. The company plans to submit a New Drug Application (NDA) in early 2026 following a successful pre-NDA meeting with the FDA.

PRAX - The company received FDA Breakthrough Therapy Designation, which accelerates development and regulatory review. Positive Phase 3 trial results and successful pre-NDA alignment with FDA support faster advancement toward commercialization. The designation addresses a significant unmet medical need in a large patient population (7 million in the US), representing substantial commercial opportunity.

#Breakthrough Therapy Designation #ulixacaltamide #essential tremor #FDA approval #NDA submission #T-type calcium channels #Phase 3 clinical trial

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

GlobeNewswire Inc. • Not Specified

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

12/29/2025 08:00 AM • Reviva Pharmaceuticals Holdings, Inc. announced that its Founder, President, and CEO Laxminarayan Bhat will present at the Sachs 9th Annual Neuroscience Innovation Forum on January 11, 2026, in San Francisco. The late-stage biopharmaceutical company is developing therapies for CNS, inflammatory, and cardiometabolic diseases, with two main drug candidates: brilaroxazine (RP5063) and RP1208.

KLXY - Rising for five consecutive sessions, reflecting growing confidence in luxury brands
RVPH - The article is primarily a conference presentation announcement with standard corporate disclosure. While the company mentions ongoing FDA interactions and potential NDA submission timelines for brilaroxazine, the main content is promotional in nature. The regulatory update referenced suggests FDA requested additional Phase 3 data, which is neither particularly positive nor negative, representing a typical development pathway adjustment.

#Reviva Pharmaceuticals #brilaroxazine #RP5063 #RP1208 #CNS diseases #schizophrenia #FDA #NDA submission #Phase 3 trial #biopharmaceutical

BiomX Announces $3.0 Million Private Placement

GlobeNewswire Inc. • Biomx Inc.

BiomX Announces $3.0 Million Private Placement

12/29/2025 08:00 AM • BiomX Inc. announced a private placement financing of approximately $3.0 million gross proceeds through the issuance of Series Y Convertible Preferred Stock and warrants. The company plans to use net proceeds to assess opportunities for its bacteriophage programs, including BX011 for diabetic foot infections, and for general corporate purposes while evaluating strategic alternatives.

DECK - Included in top luxury index, indicating potential for growth in high-end market
PHGE - The company secured $3.0 million in funding, which is positive for liquidity. However, the relatively modest funding amount, ongoing evaluation of strategic alternatives, and discontinuation of the BX004 CF trial (mentioned in supplementary content) suggest financial constraints and development challenges. The neutral sentiment reflects both the capital raise and underlying operational uncertainties.

#private placement #convertible preferred stock #warrants #phage therapy #BX011 #financing #strategic alternatives

Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico

GlobeNewswire Inc. • Theriva Biologics, Inc.

Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico

12/29/2025 08:00 AM • Theriva Biologics received favorable scientific advice from the European Medicines Agency (EMA) on the design of a Phase 3 clinical trial for VCN-01 in combination with gemcitabine/nab-paclitaxel for treating metastatic pancreatic ductal adenocarcinoma (PDAC). The EMA approved the proposed trial design, sample size, and adaptive design elements. The company plans to meet with the FDA in H1 2026 for a multinational Phase 3 trial and has cash runway through Q1 2027.

LRLCY - Part of top luxury index holdings, positioned to benefit from premium consumer trends
TOVX - The company received favorable regulatory guidance from the EMA on its lead candidate VCN-01, with approval of the Phase 3 trial design including sample size and dosing regimen. The EMA's recognition of improved survival outcomes with multiple VCN-01 doses and acceptance of repeated dosing cycles strengthens the development pathway. Planned FDA meeting in H1 2026 and adequate cash runway through Q1 2027 support near-term progress on pivotal trials.

#VCN-01 #pancreatic cancer #Phase 3 trial #EMA approval #gemcitabine/nab-paclitaxel #oncolytic adenovirus #retinoblastoma #clinical development

CCH Holdings Projects Multiple Acquisitions, New Business Ventures and International Expansion in 2026

GlobeNewswire Inc. • Cch Holdings Ltd

CCH Holdings Projects Multiple Acquisitions, New Business Ventures and International Expansion in 2026

12/29/2025 08:00 AM • CCH Holdings Ltd, a Malaysia-based specialty hotpot restaurant chain, announced plans for 2026 including acquisitions of multiple Malaysian restaurant chains, new business ventures in Malaysia, and expansion into the U.S. and Africa markets. The company aims to leverage these developments to drive growth and maximize shareholder value.

CFRUY - Jewelry spending accelerated to 16%, indicating strong luxury market performance
CCHH - The company announced ambitious growth plans including multiple acquisitions, new business ventures, and international expansion to the U.S. and Africa. These strategic initiatives signal management confidence and growth trajectory. However, the sentiment is tempered by the safe harbor statement acknowledging that these plans 'might not materialize as planned or materialize at all,' introducing execution risk.

#acquisitions #international expansion #Malaysia #hotpot restaurants #business ventures #U.S. expansion #Africa expansion

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc. • Na

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

12/29/2025 08:00 AM • Inspire Medical Systems announced that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 at 12:45 p.m. ET. The presentation will be available via live webcast and replay.

INSP - The announcement is a routine corporate event notification regarding a scheduled investor conference presentation. It contains no material business updates, financial performance indicators, or strategic developments that would warrant positive or negative sentiment. It is a standard disclosure of participation in an industry conference.

#J.P. Morgan Healthcare Conference #investor presentation #obstructive sleep apnea #neurostimulation technology #medical device

Datavault AI Inc. Announces Proposed Dividend of Warrants

Benzinga • Globe Newswire

Datavault AI Inc. Announces Proposed Dividend of Warrants

12/29/2025 07:55 AM • Datavault AI (NASDAQ: DVLT) announced a proposed special dividend distribution of warrants to common stockholders. The record date is set for January 7, 2026, with eligible shareholders receiving one warrant for every 60 shares owned. The warrants will have a $5.00 strike price, be exercisable for one year, and require holders to own at least one Dream Bowl Meme Coin II token to exercise them.

CSCO - Mentioned as lifting outlook, suggesting potential positive market performance
DVLT - The announcement of a warrant dividend is a corporate action that could be viewed positively as shareholder value distribution, but the requirement to hold a meme coin token (Dream Bowl Meme Coin II) to exercise warrants introduces significant uncertainty and risk. The conditional nature of the dividend, board's ability to revoke it, and the speculative nature of the meme coin requirement create a mixed outlook that warrants a neutral stance rather than clearly positive or negative.

#warrant dividend #special dividend #strike price #record date #digital wallet requirement #meme coin token

Benzinga • Lekha Gupta

Why Is Brand Engagement Network Stock Gaining Monday?

12/29/2025 07:48 AM • Brand Engagement Network (NASDAQ: BNAI) stock rose 20% in premarket trading Monday following the finalization of a Vendor Services Project Agreement with a global advertising agency to develop an AI engagement solution for a top-10 pharmaceutical company. The deal includes $250k in development revenue in Q4 2025 and ongoing monthly licensing fees starting Q1 2026. The company also reported a $2.5 million decrease in total liabilities through settlements and debt-to-equity conversions.

DIA - Article highlights record-breaking performance and potential for continued gains
BNAI - Stock gained 20% on news of a significant vendor services agreement with a major advertising agency for a top-10 pharmaceutical company, generating $250k in Q4 2025 revenue and recurring licensing fees starting Q1 2026. Additional positive factors include debt reduction of $2.5 million and expansion into Mexico with Skye Salud launch, demonstrating growing adoption of the company's AI technology and improving financial position.

#Brand Engagement Network #AI engagement solution #pharmaceutical #licensing fees #debt reduction #Mexico expansion #stock gain

Is the Current Price Offering a Rare Opportunity to Buy Ford Stock?

The Motley Fool • Neil Patel

Is the Current Price Offering a Rare Opportunity to Buy Ford Stock?

12/29/2025 07:32 AM • Ford Motor Company trades at an attractive valuation with a forward P/E of 9.5 and 4.5% dividend yield, up 35% year-to-date. However, the analyst argues this is not a rare buying opportunity, citing Ford's decade-long underperformance (64% total return vs. market), low growth prospects, compressed margins, high capital expenditure needs, intense competition, and cyclical demand sensitivity as reasons to avoid the stock.

F - Despite cheap valuation and attractive dividend yield, the analyst explicitly states this is not a rare opportunity worth taking. Ford faces structural challenges including low growth prospects, compressed profit margins, high capital requirements, intense competition, and cyclical demand sensitivity. The stock's 10-year underperformance (64% return vs. market outperformance) and recent $19.5 billion EV segment writedown further support a negative outlook.

#Ford stock valuation #dividend yield #automotive industry #underperformance #EV segment writedown #capital expenditure

Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares

GlobeNewswire Inc. • Na

Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares

12/29/2025 06:59 AM • Dimensional Fund Advisors Ltd. has disclosed a 5.70% interest in American Axle & Manufacturing Holdings Inc., comprising 6,764,257 USD 0.01 common shares as of December 24, 2025. The disclosure includes a recent purchase of 5,525 shares at $6.4309 per share and a transfer in of 3,325 shares. Dimensional also made concurrent disclosures regarding Dowlais Group PLC in relation to the same offer.

AXL - This is a regulatory disclosure of an investment position. The 5.70% stake and recent share purchases indicate investor confidence, but the disclosure itself is a factual regulatory filing without inherent positive or negative implications. The sentiment is neutral as it represents standard market activity and transparency.

#Form 8.3 #takeover disclosure #stake disclosure #investment position #relevant securities

Form 8.3 - [IQE PLC - 24 12 2025] - (CGAML)

GlobeNewswire Inc. • Na

Form 8.3 - [IQE PLC - 24 12 2025] - (CGAML)

12/29/2025 06:58 AM • Canaccord Genuity Asset Management Limited disclosed a 2.43% interest in IQE PLC as of December 24, 2025, holding 23,755,000 ordinary shares. The disclosure also noted a sale of 100,000 shares at 5.006p per share. This represents a public opening position disclosure under Takeover Code Rule 8.3.

IQEPY - The disclosure is a regulatory filing indicating a significant shareholding position (2.43%) by an asset manager. While the accompanying share sale of 100,000 shares could suggest slight profit-taking or portfolio adjustment, the overall disclosure is factual and regulatory in nature with no clear positive or negative implications for the company's fundamentals or prospects.

#IQE PLC #Canaccord Genuity Asset Management #stake disclosure #Form 8.3 #Takeover Code #share sale

DHT Holdings, Inc. announces the sale of two VLCCs

GlobeNewswire Inc. • Na

DHT Holdings, Inc. announces the sale of two VLCCs

12/29/2025 06:57 AM • DHT Holdings announced the sale of two crude oil tankers (DHT China and DHT Europe) for a combined $101.6 million. After debt repayment of $5.6 million, the company expects net cash proceeds of approximately $95.0 million and will record gains of $30.4 million and $29.7 million respectively from the sales. Both vessels, built in 2007, are expected to be delivered in Q1 2026.

CMCSA - Company is investing $4 billion in California technology infrastructure, expanding rural internet access, and supporting local community digital opportunities through grants and library contributions
DHT - The company is generating significant net cash proceeds ($95 million) and substantial gains ($60.1 million combined) from the asset sale. This demonstrates effective capital allocation and provides liquidity for potential dividends, debt reduction, or share buybacks, which aligns with the company's stated disciplined capital allocation strategy.